Access to Rheumatoid Arthritis Medicines in Exchange Plans (2015)

Access to Multiple Sclerosis Medicines in Exchange Plans (2015)

Access to Diabetes Medicines in Exchange Plans (2015)

Access to Asthma Medicines in Exchange Plans (2015)

Access to Oncology Medicines in Exchange Plans (2015)

Access to HIV/AIDS Medicines in Exchange Plans (2015)

Access to Mental Health Medicines in Exchange Plans (2015)

PhRMA Special 301 Submission 2015

Patient Safety Demands that Drug Compounders Comply With Law

12.11.14 | By

“When compounded products are not made according to strict quality standards appropriate for their scale of production, the results can be deadly.”  Six public health organizations wrote this to FDA Commissioner Hamburg to voice strong support on FDA’s robust enforcement of the federal law on compounding.

ICYMI: New Study Highlights Often High Out-of-Pocket Costs in Exchanges

11.20.14 | By

Earlier this week, the Kaiser Family Foundation released new research about the deductibles in different health insurance exchange plans. The study found for bronze or silver plans patients often have to pay thousands of dollars out of pocket due to high combined deductibles.

Pages

Subscribe to RSS - Access